The government's role as a main actor in pharmaceuticals R&D: a case study
| Autor: | Marinho,Vera Maria Costa, Seidl,Peter Rudolf, Longo,Waldimir Pirró e |
|---|---|
| Jazyk: | portugalština |
| Rok vydání: | 2008 |
| Předmět: | |
| Zdroj: | Química Nova, Volume: 31, Issue: 7, Pages: 1912-1917, Published: 2008 Química Nova v.31 n.7 2008 Química Nova Sociedade Brasileira de Química (SBQ) instacron:SBQ |
| Popis: | The importance of natural products as a source of new high value-added drugs has, no doubt, transformed Brazilian megadiversity into one of the country's most valuable and strategic assets. Thus the rational exploration of the Brazilian flora on an economic basis should be considered as part of a national development strategy. In this respect, governmental mechanisms to stimulate regulation on the access, bioprospection and industrial use of natural products represent a crucial issue. The aim of this paper is to show how the incentives and institutional arrangements that led to one of the greatest breakthroughs in the pharmaceutical industry, the development and commercialization of the anti-cancer agent Taxol, could be applied to the Brazilian case. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|